naltrexone has been researched along with Somatoform Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helwig, H; Jahn, H; Kiefer, F; Otte, C; Tarnaske, T; Wiedemann, K | 1 |
| Freye, E; Levy, J | 1 |
| Grey, C; Osborn, E; Reznikoff, M | 1 |
1 trial(s) available for naltrexone and Somatoform Disorders
| Article | Year |
|---|---|
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Anxiety Disorders; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotics; Predictive Value of Tests; Prospective Studies; Secondary Prevention; Somatoform Disorders; Surveys and Questionnaires; Taurine; Treatment Outcome | 2005 |
2 other study(ies) available for naltrexone and Somatoform Disorders
| Article | Year |
|---|---|
Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal.
Topics: Acute Disease; Animals; Biotransformation; Dogs; Evoked Potentials, Somatosensory; Naltrexone; Narcotics; Protein Kinase C; Receptors, Opioid; Somatoform Disorders; Substance Withdrawal Syndrome; Sufentanil | 2005 |
Psychosocial factors in outcome in two opiate addiction treatments.
Topics: Adult; Family; Female; Humans; Life Change Events; Male; Methadone; Middle Aged; Motivation; Naltrexone; Opioid-Related Disorders; Patient Compliance; Psychophysiologic Disorders; Social Support; Somatoform Disorders | 1986 |